BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8111816)

  • 1. The efficacy and safety of once-daily nifedipine coat-core in the treatment of mild-to-moderate hypertension. Adalat CC Cooperative Study Group.
    Feig PU; Gibson L; Mac Carthy EP; Pettis PP; Schwartz L
    Clin Ther; 1993; 15(6):963-75. PubMed ID: 8111816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety and efficacy of once-daily nifedipine coat-core in combination with atenolol in hypertensive patients. Adalat CC Cooperative Study Group.
    Mac Carthy EP; Pettis PP; Gibson L; Schwartz L; Feig PU
    Clin Ther; 1993; 15(6):976-87. PubMed ID: 8111817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
    Fagan TC; Haggert BE; Liss C
    Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of enalapril versus extended-release nifedipine for the treatment of mild-to-moderate essential hypertension: a multicenter 22-week study. Multicenter Cooperative Study Group.
    Leon AS
    Clin Ther; 1993; 15(6):1094-107. PubMed ID: 8111807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive efficacy of a slow release nifedipine tablet formulation given once daily in patients with mild to moderate hypertension. A placebo-controlled, double-blind parallel-group trial.
    Harder S; Rietbrock S; Thürmann P
    Arzneimittelforschung; 1994 Feb; 44(2):133-6. PubMed ID: 8147945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
    Svetkey LP; Weinberger MH; Gavras H; Gavras I; Brown TS; Deterding J; Klotman PE
    J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump.
    de Roa ER; Botero R; Octavio JA; Berrizbeitia ML; Mayorca E; Castro P; Miranda R; Valecillo E; Aroca G; Aza G; González M
    Am J Ther; 2007; 14(2):140-6. PubMed ID: 17414581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New sustained-release nifedipine formulation in treatment of essential hypertension. Unidipin Cooperative Study Group.
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):349-53. PubMed ID: 1378112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the effects of two modified release preparations of nifedipine-nifedipine retard 10 mg twice daily and nifedipine GITS 20 mg once daily--in the treatment of mild to moderate hypertension.
    Kirby BJ; Kitchin NR
    Int J Clin Pract; 1999; 53(5):339-43. PubMed ID: 10695096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C; Romanet JP; Nordmann JP; Allaire C;
    J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lisinopril versus slow-release nifedipine in the treatment of mild to moderate hypertension: a multicentre study. The Cooperative Study Group.
    Witchitz S; Serradimigni A
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():29-33. PubMed ID: 2550643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lisinopril versus slow release nifedipine in patients with essential hypertension: a multicentre study.
    Predel HG; Kramer HJ
    J Hum Hypertens; 1994 Oct; 8(10):777-80. PubMed ID: 7837215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind comparison of amlodipine and nifedipine retard in the treatment of mild to moderate hypertension.
    Lorimer AR; Anderson JA; Laher MS; Davies J; Lazarus JH; Taylor SH; Sanghera S
    J Hum Hypertens; 1994 Jan; 8(1):65-8. PubMed ID: 8151609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter evaluation of the efficacy and safety of sustained-release diltiazem hydrochloride for the treatment of hypertension.
    Woehler TR; Eff J; Graney W; Heald D; Ziemniak J; Magner D
    Clin Ther; 1992; 14(2):148-57. PubMed ID: 1611639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC; Fiske K; Lyne A
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Side effects of dihydropyridine therapy: comparison of amlodipine and nifedipine retard.
    Hosie J; Bremner AD; Fell PJ; James GV; Saul PA; Taylor SH
    J Cardiovasc Pharmacol; 1993; 22 Suppl A():S9-12. PubMed ID: 7522287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group.
    Dahlöf B; Hosie J
    Blood Press Suppl; 1993; 1():22-9. PubMed ID: 8173687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.